Cartesian Therapeutics, Inc. (RNAC) Revenue 2016–2025
Cartesian Therapeutics, Inc. (RNAC) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$400,000FY2025 · since FY2016: $8.1M → $400,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $400,000 | -99.0% |
| FY2024 | $38.3M | +47.2% |
| FY2023 | $26.0M | -76.5% |
| FY2022 | $110.8M | +30.2% |
| FY2021 | $85.1M | +412.6% |
| FY2020 | $16.6M | +148.6% |
| FY2019 | $6.7M | +639.4% |
| FY2018 | $903,000 | +336.2% |
| FY2017 | $207,000 | -97.4% |
| FY2016 | $8.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice